ArticleScience translational medicine2011
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.
Alessia Fornoni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
300 papers cite itlatest 60 shown
this paperpooled ittrialcites it